Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

Activity: Talk or presentation typesLecture and oral contribution

Jesper Bøje Andersen - Speaker

    Current Perspectives and Future Challenges in Gastroenterological-malignancies. National Institutes of Health, GI-Malignancy Faculty, Bethesda USA
    2011

    External organisation

    NameUnknown external organisation

    ID: 96522503